Charles Willis
Neurology · Greensboro, NCNPI 1427014497
Payments from drug & device makers
Across 165 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$274
- Novartis$253
- UCB, Inc.$229
- AbbVie$221
- Sanofi$173
- Greenwich Biosciences, Inc.$110
- plus $2K from 40 others
What the payments were for
- Speaking & faculty fees$371%
- Food & beverage$2,76599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,803 in reported general payments places this provider in the 60th percentile of 566 neurology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 14 | $307 |
| Buspirone Hcl | 13 | $240 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $224 |
Paid to pharmacies, not to this prescriber.
Other neurology in Greensboro
- Pramod SethiGreensboro$2.9M
- Marshall FreemanGreensboro$1.9M
- Richard SaterGreensboro$1.9M
- Mohammad BolouriCharlotte$16.6M
- Katherine PetersDurham$11M
- John ScagnelliRaleigh$9.3M
- T RaoCharlotte$4M
- Robert ArmstrongAsheville$2.7M
- Casey JeffreysRaleigh$2.2M
- Mitchell IsaacWinston Salem$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.